M
Multiply Labs
Robotic clusters that automate cell and gene therapy manufacturing
About Multiply Labs
Multiply Labs is a San Francisco deep-tech company founded by MIT alumni CEO Fred Parietti, Ph.D., and CSO Alice Melocchi that builds robotic biomanufacturing infrastructure for cell and gene therapies and advanced biologics. Its modular robotic Cluster connects existing GMP-grade instruments inside a closed, automated environment, learning manufacturer workflows through imitation learning rather than full process transfer, and pairs with Digital QC software for real-time sensor monitoring and 21 CFR Part 11-compliant electronic batch records. Partners and collaborators named in company materials include AstraZeneca, Legend Biotech, Kyverna Therapeutics, Thermo Fisher Scientific and Stanford’s Laboratory for Cell and Gene Medicine. In September 2026 Multiply Labs raised $75 million in Series B funding, with participation reported from AstraZeneca Ventures, Lingotto, Legend Biotech and Strange Ventures alongside returning Casdin Capital, Lux Capital and Founders Fund, to expand manufacturing capacity and accelerate commercial-scale product development. Sources: Datapile / Dealroom note Sep 2026; company site.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2016
- Headquarters
- San Francisco, United States
- Employees
- 73
- Open positions
- 5
- Dealroom signal
- 89.3/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Nutrition, Precision Medicine, Spinout, Tech for Biotech and Pharma, Techbio, Hard Tech
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Apr 2021 | $20M | $80M | Garage Capital · Lux Capital · Fifty Years · Founders Fund | — |
| EARLY VC✓Equity / VC | May 2017 | $2.7M | $11M | Pegasus Tech Ventures · Pacific 8 Ventures · P101 Ventures · Graph Ventures | — |
Growth signals
Latest recorded traffic for Multiply Labs is 6.2K monthly website visits, up 82.4% over the last three months. Multiply Labs's team grew 23.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Tank Stream Ventures
Y Combinator
Series A10 investors entered at this stage
Pegasus Tech Ventures- PVPacific 8 Ventures
P101 Ventures
Graph Ventures
CRCM Ventures
Casdin Capital
Garage Capital
Lux Capital
Fifty Years
Founders Fund
Other known investors7 additional known investors
University of Milan
Andrea Di Camillo
Naveen Jain
Ora Global
SV Tech Ventures
Tim Marbach
Wisemont Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Multiply Labs on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Multiply Labs’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.